Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The role of the opioid system in controlling pain, reward and addiction is well established, but its role in regulating other emotional responses is poorly documented in pharmacology. The mu-, delta- and kappa- opioid receptors (encoded by Oprm, Oprd1 and Oprk1, respectively) mediate the biological activity of opioids. We have generated Oprd1-deficient mice and compared the behavioural responses of mice lacking Oprd1, Oprm (ref. 6) and Oprk1 (ref. 7) in several models of anxiety and depression. Our data show no detectable phenotype in Oprk1-/- mutants, suggesting that kappa-receptors do not have a role in this aspect of opioid function; opposing phenotypes in Oprm-/- and Oprd1-/- mutants which contrasts with the classical notion of similar activities of mu- and delta-receptors; and consistent anxiogenic- and depressive-like responses in Oprd1-/- mice, indicating that delta-receptor activity contributes to improvement of mood states. We conclude that the Oprd1-encoded receptor, which has been proposed to be a promising target for the clinical management of pain, should also be considered in the treatment of drug addiction and other mood-related disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, agonism of the delta-opioid receptor, the primary receptor target of enkephalin, promotes antidepressant outcomes (80), while delta receptor knockout promotes depressive-like behavior (81).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [81]
Citations
Cites
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
Self-citationOpioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
Mansour, A., Fox, C. A., Akil, H., & Watson, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93946-u · Cited by 1,292
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010
Self-citationTimpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., & Wurst, W. (1998) · Nature Genetics · doi:10.1038/520 · Cited by 919
Lufkin, T., Dierich, A., LeMeur, M., Mark, M., & Chambon, P. (1991) · Cell · doi:10.1016/0092-8674(91)90034-v · Cited by 697
Self-citationDecreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues
Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J. P., Belzung, C., Fritschy, J.-M., Lüscher, B., & Mohler, H. (1999) · Nature Neuroscience · doi:10.1038/12207 · Cited by 550
Cited by
Items 301–400 of 692
Factors Associated with Opioid Use in a Cohort of Patients Presenting for Surgery
Hah, J. M., Sharifzadeh, Y., Wang, B. M., Gillespie, M., Goodman, S. B., Mackey, S., & Carroll, I. R. (2015) · Pain Research and Treatment · doi:10.1155/2015/829696 · Cited by 34
Chang, L., Kigar, S. L., Ho, J. H., Cuarenta, A., Gunderson, H. C., Baldo, B. A., Bakshi, V. P., & Auger, A. P. (2018) · Brain Research · doi:10.1016/j.brainres.2018.12.040 · Cited by 35
Tianeptina, un abordaje farmacológico atípico de la depresión
Álamo, C., García‐García, P., Lopez-Munoz, F. J., & Zaragozá, C. (2019) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2018.09.002 · Cited by 36
Torregrossa, M. M., Folk, J. E., Rice, K. C., Watson, S. J., & Woods, J. H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0113-5 · Cited by 35
RB101‐mediated Protection of Endogenous Opioids: Potential Therapeutic Utility?
Jutkiewicz, E. M. (2007) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2007.00011.x · Cited by 33
Valenza, M., Picetti, R., Yuferov, V. P., Butelman, E. R., & Kreek, M. J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.004 · Cited by 37
Maternal Weaning Modulates Emotional Behavior and Regulates the Gut-Brain Axis
Farshim, P., Walton, G., Chakrabarti, B., Givens, I., Saddy, D., Kitchen, I., R. Swann, J., & Bailey, A. (2016) · Scientific Reports · doi:10.1038/srep21958 · Cited by 32
Phenotypes of mice with invalidation of cholecystokinin (CCK1 or CCK2) receptors
Noble, F., & Roques, B. P. (2002) · Neuropeptides · doi:10.1054/npep.2002.0904 · Cited by 37
Pharmacogenetics of Addiction Therapy
Nielsen, D. A., Nielsen, E. M., Dasari, T., & Spellicy, C. J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0956-8_15 · Cited by 33
Mann, A., Liebetrau, S., Klima, M., Dasgupta, P., Massotte, D., & Schulz, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-65589-7 · Cited by 32
Opiate-Induced Analgesia: Contributions From Mu, Delta and Kappa Opioid Receptors Mouse Mutants
Gavériaux‐Ruff, C. (2014) · Current Pharmaceutical Design · doi:10.2174/138161281942140105163727 · Cited by 32
Self-citationRamon‐Duaso, C., Gener, T., Consegal, M., Fernández-Avilés, C., Gallego, J., Castarlenas, L., Swanson, M. S., de la Torre, R., Maldonado, R. J., Puig, M. V., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy164 · Cited by 35
Self-citationXie, Z., Li, Z., Guo, L., Ye, C., Li, J., Yu, X., Yang, H., Wang, Y., Chen, C., Zhang, D., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.03.005 · Cited by 32
Bailey, A., Matthes, H. W. D., Kieffer, B. L., Slowe, S. J., Hourani, S. M. O., & Kitchen, I. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02536-2 · Cited by 32
Self-citationAnalysis of severe feather pecking behavior in a high feather pecking selection line
Labouriau, R., Kjær, J. B., de Abreu, G. C. G., Hedegaard, J., & Buitenhuis, B. (2009) · Poultry Science · doi:10.3382/ps.2009-00113 · Cited by 33
Tóth, P., Décaillot, F. M., Filliol, D., Befort, K., Lazarus, L. H., Schiller, P. W., Schmidhammer, H., & Kieffer, B. L. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077321 · Cited by 32
Self-citationThe Local Anesthetic and Pain Relief Activity of Alkaloids
Sayhan, H., Beyaz, S. G., & Çeliktaş, A. (2017) · InTech eBooks · doi:10.5772/intechopen.69847 · Cited by 31
Self-Loathing Aspects of Depression Reduce Postoperative Opioid Cessation Rate
Hah, J. M., Mackey, S., Barelka, P. L., Wang, C. K. M., Wang, B. M., Gillespie, M., McCue, R., Younger, J., Trafton, J. A., Humphreys, K. N., et al. (2014) · Pain Medicine · doi:10.1111/pme.12439 · Cited by 31
Agonist activity of N-desmethylclozapine at δ-opioid receptors of human frontal cortex
Olianas, M. C., Dedoni, S., Ambu, R., & Onali, P. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.02.025 · Cited by 31
Delta Opioid Receptors: Learning and Motivation
Pellissier, L. P., Pujol, C., Becker, J. A. J., & Merrer, J. L. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_89 · Cited by 34
Delta Opioid Receptors and Modulation of Mood and Emotion
Dripps, I. J., & Jutkiewicz, E. M. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_42 · Cited by 37
Analgesia linked to Nav1.7 loss of function requires µ- and δ-opioid receptors
Pereira, V., Millet, Q., Aramburu, J. F., López‐Rodríguez, C., Gavériaux‐Ruff, C., & Wood, J. N. (2018) · Wellcome Open Research · doi:10.12688/wellcomeopenres.14687.1 · Cited by 33
Self-citationEmerging Treatment Targets for Migraine and Other Headaches
Bertels, Z., & Pradhan, A. A. A. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13585 · Cited by 32
Deletion of the mu opioid receptor results in impaired acquisition of Pavlovian context fear
Sanders, M. J., Kieffer, B. L., & Fanselow, M. S. (2005) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2005.03.001 · Cited by 34
Self-citationBurghardt, P. R., & Wilson, M. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300864 · Cited by 31
A New Generation of Drugs: Synthetic Peptides Based on Natural Regulatory Peptides
Kolomin, T., Shadrina, M., Slominsky, P., Limborska, S., & Myasoedov, N. (2013) · Neuroscience and Medicine · doi:10.4236/nm.2013.44035 · Cited by 30
“Thus, animals with knockout of δ-opioid receptors exhibit elevated levels of anxiety [156].”
BackgroundThe atypical antidepressant mianserin exhibits agonist activity at κ‐opioid receptors
Olianas, M. C., Dedoni, S., & Onali, P. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02078.x · Cited by 32
Food protein-derived anxiolytic peptides: their potential role in anxiety management
Hafeez, Z., Benoit, S., Cakir‐Kiefer, C., Dary, A., & Miclo, L. (2020) · Food & Function · doi:10.1039/d0fo02432e · Cited by 34
Gavériaux‐Ruff, C., Filliol, D., Simonin, F., Matthes, H. W. D., & Kieffer, B. L. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29492-1 · Cited by 30
Self-citationThe molecular neurobiology of stress – evidence from genetic and epigenetic models
Steckler, T. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200111000-00002 · Cited by 32
Mohammadkhani, A., & Borgland, S. L. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24770 · Cited by 32
García‐Sevilla, J. A., Ferrer‐Alcón, M., Martín, M., Kieffer, B. L., & Maldonado, R. J. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.10.006 · Cited by 29
Self-citationImpact of chronic morphine on delta opioid receptor-expressing neurons in the mouse hippocampus
Erbs, E., Faget, L. C., Ceredig, R. A., Matifas, A., Vonesch, J., Kieffer, B. L., & Massotte, D. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.022 · Cited by 31
Self-citationThe effect of opiodergic system and testosterone on anxiety behavior in gonadectomized rats
Khakpai, F. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.01.013 · Cited by 29
Ambrose‐Lanci, L. M., Sterling, R. C., & Bockstaele, E. J. V. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22259 · Cited by 29
Discovery of Novel Triazole-Based Opioid Receptor Antagonists
Zhang, Q., Keenan, S. M., Peng, Y., Nair, A. C., Yu, S. J., Howells, R., & Welsh, W. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0601250 · Cited by 32
Kang-Park, M.-H., Kieffer, B. L., Roberts, A. J., Roberto, M., Madamba, S. G., Siggins, G. R., & Moore, S. D. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.140749 · Cited by 28
Self-citationHuang, P., Tunis, J., Parry, C., Tallarida, R. J., & Liu‐Chen, L. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.03.061 · Cited by 32
Regulation of Opioid Receptors by Their Endogenous Opioid Peptides
Gupta, A., Gullapalli, S., Pan, H., Ramos‐Ortolaza, D. L., Hayward, M. D., Low, M. J., Pintar, J. E., Devi, L. A., & Gomes, I. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-01015-w · Cited by 28
Slowe, S. J., Clarke, S., Léna, I., Goody, R. J., Lattanzi, R., Negri, L., Simonin, F., Matthes, H. W. D., Filliol, D., Kieffer, B. L., et al. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00308-6 · Cited by 39
Self-citationChefer, V. I., & Shippenberg, T. S. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04525.x · Cited by 28
Enkephalin knockout male mice are resistant to chronic mild stress
Melo, I., Drews, E., Zimmer, A., & Bilkei‐Gorzo, A. (2014) · Genes, Brain and Behavior · doi:10.1111/gbb.12139 · Cited by 27
A Study of the Coupling of FET Temperament Traits with Major Depression
Trofimova, I. N., & Sulis, W. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.01848 · Cited by 27
Chefer, V. I., Kieffer, B. L., & Shippenberg, T. S. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.021 · Cited by 27
Self-citationCocaine withdrawal-induced trafficking of delta-opioid receptors in rat nucleus accumbens
Ambrose‐Lanci, L. M., Peiris, N., Unterwald, E. M., & Bockstaele, E. J. V. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.105 · Cited by 30
Fiorelli, R., Rudolph, U., Straub, C. J., Feldon, J., & Yee, B. K. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830dc0c7 · Cited by 26
Eisinger, B. E., Driessen, T. M., Zhao, C., & Gammie, S. C. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00110 · Cited by 28
Tianeptine, an atypical pharmacological approach to depression
Álamo, C., García‐García, P., Lopez-Munoz, F. J., & Zaragozá, C. (2019) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2018.09.001 · Cited by 30
Mu and delta opioid receptor knockout mice show increased colonic sensitivity
Reiss, D., Ceredig, R. A., Sécher, T., Boué, J., Barreau, F., Dietrich, G., & Gavériaux‐Ruff, C. (2016) · European Journal of Pain · doi:10.1002/ejp.965 · Cited by 27
Self-citationKimura, S., Uchida, T., Tokuyama, Y., Hosokawa, M., Nakato, J., Kurabayashi, A., Satô, M., Suzuki, H., Kanamoto, R., & Ohinata, K. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.195 · Cited by 26
Opioid receptors: From genes to mice
Kieffer, B. L. (2000) · Journal of Pain · doi:10.1054/jpai.2000.9823 · Cited by 28
Self-citationZaidi, S. A., Arnatt, C. K., He, H., Selley, D. E., Mosier, P. D., Kellogg, G. E., & Zhang, Y. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.08.042 · Cited by 27
Latagliata, E. C., Valzania, A., Pascucci, T., Campus, P., Cabib, S., & Puglisi‐Allegra, S. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3549-7 · Cited by 28
Zheng, Y., Obeng, S., Wang, H., Jali, A. M., Peddibhotla, B., Williams, D. A., Zou, C., Stevens, D. L., Dewey, W. L., Akbarali, H. I., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01158 · Cited by 25
Lyu, S., DeAndrade, M. P., Mueller, S., Oksche, A., Walters, A. S., & Li, Y. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112123 · Cited by 25
Association of Rare Genetic Variants in Opioid Receptors with Tourette Syndrome
Depienne, C., Ciura, S., Trouillard, O., Bouteiller, D., Leitão, E., Nava, C., Keren, B., Marie, Y., Guégan, J., Forlani, S., et al. (2019) · Tremor and Other Hyperkinetic Movements · doi:10.7916/d8-set6-yg22 · Cited by 26
Urigüen, L., Berrendero, F., Ledent, C. A., Maldonado, R. J., & Manzanares, J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04372.x · Cited by 25
Self-citationSacharczuk, M., Juszczak, G. R., Swiergiel, A. H., Jaszczak, K., Lipkowski, A. W., & Sadowski, B. (2009) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2009-1757 · Cited by 26
Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities
Gaborit, M., & Massotte, D. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15772 · Cited by 25
Prolonged morphine treatment alters δ opioid receptor post‐internalization trafficking
Ong, E. W., Xue, L., Olmstead, M. C., & Cahill, C. M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12761 · Cited by 26
Solati, J. (2011) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2011.06.011 · Cited by 24
Gender differences in genetic mouse models evaluated for depressive-like and antidepressant behavior
Kreiner, G., Chmielarz, P., Roman, A., & Nalepa, I. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71519-6 · Cited by 25
Endogenous opioid system: a promising target for future smoking cessation medications
Norman, H., & D’Souza, M. S. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4582-0 · Cited by 26
Animal models of major depressive disorder and the implications for drug discovery and development
Demin, K. A., Sysoev, M., Chernysh, M. V., Savva, A. K., Koshiba, M., Wappler-Guzzetta, E. A., Song, C., de Abreu, M. S., Leonard, B. E., Parker, M. O., et al. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1575360 · Cited by 26
Jutkiewicz, E. M., & Roques, B. P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.244 · Cited by 24
The neural circuits and signalling pathways of opioid use disorder
Mathis, V., Ehrlich, A. T., & Darcq, E. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00982-7 · Cited by 25
Buprenorphine treatment for opioid use disorder: recent progress
Parida, S., Carroll, K. M., Petrakis, I. L., & Sofuoglu, M. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1635454 · Cited by 23
Secondulfo, C., Mazzeo, F., Pastorino, G. M. G., Vicidomini, A., Meccariello, R., & Operto, F. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179407 · Cited by 25
Atigari, D. V., Uprety, R., Pasternak, G. W., Majumdar, S., & Kivell, B. M. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.010 · Cited by 23
Zhou, W., Li, Y., Meng, X., Liu, A., Mao, Y., Zhu, X., Meng, Q., Jin, Y., Zhang, Z., & Tao, W. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100277 · Cited by 24
Trabanco, A. A., Aerts, N., Álvarez, R. M., Andrés, J. I., Boeckx, I., Fernández, J., Gómez, A., Janssens, F. E., Leenaerts, J. E., de Lucas, A. I., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.012 · Cited by 23
Narita, M., Kuzumaki, N., Narita, M., Kaneko, C., Tamai, E., Khotib, J., Miyatake, M., Shindo, K., Nagumo, Y., Tanaka, S., et al. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.067 · Cited by 23
Deo, A. J., Huang, Y.-Y., Hodgkinson, C. A., Xin, Y., Oquendo, M. A., Dwork, A. J., Arango, V., Brent, D. A., Goldman, D., Mann, J. J., et al. (2013) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32835d7028 · Cited by 20
Novel treatments for chronic pain: moving beyond opioids
O’Brien, J. B., & Roman, D. L. (2021) · Translational research · doi:10.1016/j.trsl.2021.03.008 · Cited by 23
Adžić, M., Lukić, I., Mitić, M., Glavonic, E., Dragicevic-Curic, N., & Ivković, S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121803 · Cited by 24
Zádor, F., Lénárt, N., Csibrány, B., Sántha, M., Molnar, M. F., Tuka, B., Samavati, R., Klivènyi, P., Vécsei, L., Marton, A., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.008 · Cited by 25
Desensitization of δ-opioid receptors in nucleus accumbens during nicotine withdrawal
McCarthy, M. J., Zhang, H., Neff, N. H., & Hadjiconstantinou, M. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2028-z · Cited by 23
Alongkronrusmee, D., Chiang, T., & van Rijn, R. M. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.08.017 · Cited by 23
Mu and delta opioid receptors play opposite nociceptive and behavioural roles on nerve‐injured mice
Martínez‐Navarro, M., Cabañero, D., Wawrzczak‐Bargieła, A., Robé, A., Gavériaux‐Ruff, C., Kieffer, B. L., Przewłocki, R., Baños, J.-E., & Maldonado, R. J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14911 · Cited by 25
Self-citationAlleviating pain with delta opioid receptor agonists: evidence from experimental models
Berthiaume, S., Abdallah, K., Blais, V., & Gendron, L. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02172-4 · Cited by 22
Effects of delta opioid receptors activation on a response inhibition task in rats
Befort, K., Mahoney, M. K., Chow, C., Hayton, S. J., Kieffer, B. L., & Olmstead, M. C. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2108-0 · Cited by 22
Self-citationPérez de la Mora, M., Borroto-Escuela, D. O., Crespo-Ramírez, M., Rejón-Orantes, J. D. C., Palacios-Lagunas, D. A., Martínez-Mata, M. K., Sánchez-Luna, D., Tesoro-Cruz, E., & Fuxe, K. (2022) · Cells · doi:10.3390/cells11111826 · Cited by 21
Hudzik, T. J., Pietras, M. R., CACCESE, R. G., Bui, K., Yocca, F. D., Paronis, C. A., & Swedberg, M. D. B. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.05.009 · Cited by 22
Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?
Guan, Q., Velho, R. V., Sehouli, J., & Mechsner, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021633 · Cited by 23
Mitchell, J., Margolis, E. B., Coker, A. R., Allen, D. C., & Fields, H. L. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12246 · Cited by 21
Dopamine-D1 and δ-opioid receptors co-exist in rat striatal neurons
Ambrose, L. M., Gallagher, S. M., Unterwald, E. M., & Bockstaele, E. J. V. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.02.027 · Cited by 25
Contingent Tunes of Neurochemical Ensembles in the Norm and Pathology: Can We See the Patterns?
Trofimova, I. N. (2021) · Neuropsychobiology · doi:10.1159/000513688 · Cited by 22
Distinctive modulation of ethanol place preference by delta opioid receptor-selective agonists
van Rijn, R. M., Brissett, D. I., & Whistler, J. L. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.09.024 · Cited by 21
Thoeringer, C. K., Wultsch, T., Shahbazian, A., Painsipp, E., & Holzer, P. D. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.08.001 · Cited by 24
Mouse anxiety: the power of knockout
Lesch, K. (2001) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500016 · Cited by 22
The Asp40 μ-Opioid Receptor Allele Does Not Predict Naltrexone Treatment Efficacy in Heavy Drinkers
Mitchell, J., Fields, H. L., White, R. L., Meadoff, T., Joslyn, G., & Rowbotham, M. C. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31802e68b0 · Cited by 21
Nagai, J., Kurokawa, M., Takeshima, H., Kieffer, B. L., & Ueda, H. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.115121 · Cited by 21
Self-citationTrofimova, I. N., & Sulis, W. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.00338 · Cited by 22
Reyes, B. A. S., Kravets, J. L., Connelly, K. L., Unterwald, E. M., & Bockstaele, E. J. V. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1261-6 · Cited by 23
Precision in mouse behavior genetics
Pfaff, D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101128598 · Cited by 21
Morales‐Mulia, M., Estrada-Camarena, E. M., Amaya, M. I., Mejía-Mauries, S., Sollozo-Dupont, I., Mengod, G., & de Gortari, P. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.036 · Cited by 23
Anti‐nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist
Taylor, A. M. W., Roberts, K. W., Pradhan, A. A. A., Akbari, H., Walwyn, W. M., Lutfy, K., Carroll, F. I., Cahill, C. M., & Evans, C. J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12810 · Cited by 24
Induction of depressive‐like effects by subchronic exposure to cocaine or heroin in laboratory rats
Zilkha, N., Feigin, E., Barnea‐Ygael, N., & Zangen, A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12753 · Cited by 21
Delta Opioid Pharmacology in Relation to Alcohol Behaviors
Alongkronrusmee, D., Chiang, T., & van Rijn, R. M. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_30 · Cited by 21
Opioid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Borsodi, A. D., Bruchas, M. R., Calò, G., Chavkin, C., Christie, M. J., Civelli, O., Connor, M. A., Cox, B. M., Devi, L. A., Evans, C. J., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f50/2019.4 · Cited by 23
Self-citation
Metadata
- Authors
- Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., Valverde, O., Maldonado, R., & Kieffer, B. L.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Universitat Pompeu Fabra (ES)
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- Corresponding author
- Kieffer, Brigitte L.
- ORCID
- Venue
- Nature Genetics
- Published
- 2000-06
- Volume
- 25
- Issue
- 2
- Pages
- 195-200
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1505495051
- Cited by
- 672
- References
- 31
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 15 · 2023: 19 · 2022: 18 · 2021: 16 · 2020: 24 · 2019: 29 · 2018: 28 · 2017: 30 · 2016: 41 · 2015: 24 · 2014: 39 · 2013: 35 · 2012: 33
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- delta opioid receptor, mu-opioid receptor, kappa opioid receptor, OprM, anxiety-like behavior, depression-like behavior, emotion regulation, mood disorders, drug addiction, pain
- MeSH terms
- Animals, Anxiety, Binding Sites, Darkness, Depression, Electroshock, Female, Light, Male, Motor Activity, Naloxone, Naltrexone, Narcotic Antagonists, Phenotype, Sex Characteristics, Swimming, Pain Threshold, Gene Deletion, Receptors, Opioid, mu, Receptors, Opioid, delta, Receptors, Opioid, kappa, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.